MedTrace Logo

Gene Expression Profiles in Muscle After Immunisation

NCT02368327 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 45

Last updated 2015-08-10

No results posted yet for this study

Summary

This clinical study is part of the BIOVACSAFE project which is funded by the Innovative Medicine Initiative. In this study we will take a small muscle biopsy in order to identify any differences in the response around the actual site of injection compared with responses we measure in blood at the same time.

Conditions

  • Healthy

Interventions

BIOLOGICAL

Fluad

BIOLOGICAL

Fendrix

BIOLOGICAL

Placebo

Sponsors & Collaborators

  • Max Planck Institute for Infection Biology

    collaborator OTHER

  • University of Surrey

    lead OTHER

Principal Investigators

  • Aldona Greenwood · University of Surrey

Study Design

Allocation
RANDOMIZED
Purpose
BASIC_SCIENCE
Masking
SINGLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
45 Years
Sex
MALE
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2015-02-28
Primary Completion
2015-07-31
Completion
2015-07-31

Countries

  • United Kingdom

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02368327 on ClinicalTrials.gov